Zobrazeno 1 - 10
of 69
pro vyhledávání: '"John, Mandrola"'
Publikováno v:
Journal of Evidence-Based Healthcare, Vol 2, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/affd67de6b2e4cf6b704f025dbd963d7
Publikováno v:
Journal of Evaluation in Clinical Practice.
Autor:
Mohammed Ruzieh, Rita F. Redberg, Andrew Foy, Brandon Peterson, John Mandrola, Adam Sturts, Sanket S. Dhruva, Guodong Liu
Publikováno v:
The American Journal of Cardiology. 163:8-12
This study aimed to assess long-term resource utilization and outcomes in patients with acute chest pain who underwent coronary computed tomography angiography (CCTA) and stress echocardiography (SE). This was a retrospective, propensity-matched anal
Publikováno v:
New England Journal of Medicine. 387:565-567
Autor:
David R. Tomlinson, John Mandrola
Publikováno v:
HeartRhythm Case Reports
Autor:
Piotr Futyma, John Mandrola
Publikováno v:
Trends in cardiovascular medicine.
Autor:
Domenico Pagano, Philip Home, Alar Irs, Jonathan Ledermann, Giuseppe Curigliano, Tsuguo Iwatani, John Mandrola, Nick Freemantle
Publikováno v:
Journal of the Royal Society of Medicine. 115(7)
Autor:
Gerald V. Naccarelli, Andrew Foy, Vernon M. Chinchilli, Anne Marie Dyer, Mohammed Ruzieh, John Mandrola
Publikováno v:
Drugs & Aging. 37:839-844
Multimorbidity is common in patients with cardiovascular disease. Clinical trials in cardiovascular medicine mostly enroll patients who are younger, healthier, and more affluent than average patients with the condition of interest. These trials rarel
Autor:
Jennifer L. Cooper, Matthew Nudy, Mehrdad Ghahramani, John Mandrola, Mohammed Ruzieh, Andrew Foy
Publikováno v:
The American Journal of Medicine. 133:1056-1064
Background Aspirin has long had a role in the primary prevention of atherosclerotic cardiovascular disease (ASCVD); however, recent randomized controlled trials (RCTs) have challenged this practice. Despite this, aspirin is still commonly recommended
Publikováno v:
Thrombosis and Haemostasis. 121:008-014
Four recently published randomized controlled trials have informed the care of patients with stable ischemic heart disease. The purpose of this clinical focus article is to offer a summary and critical appraisal of the recent evidence. We aim to aid